These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

68 related items for PubMed ID: 9740320

  • 1. Expression of cell death regulatory genes and limited apoptosis induction in avian blastodermal cells.
    Muscarella DE, Rachlinski MK, Bloom SE.
    Mol Reprod Dev; 1998 Oct; 51(2):130-42. PubMed ID: 9740320
    [Abstract] [Full Text] [Related]

  • 2. Cell death in the avian blastoderm: resistance to stress-induced apoptosis and expression of anti-apoptotic genes.
    Bloom SE, Muscarella DE, Lee MY, Rachlinski M.
    Cell Death Differ; 1998 Jun; 5(6):529-38. PubMed ID: 10200504
    [Abstract] [Full Text] [Related]

  • 3. Analysis of apoptosis and expression of bcl-2 gene family members in the human and baboon ovary.
    Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao XJ, Martimbeau S, Aberdeen GW, Krajewski S, Reed JC, Pepe GJ, Albrecht ED, Tilly JL.
    Cell Death Differ; 1998 Jan; 5(1):67-76. PubMed ID: 10200447
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
    Blood A, Edwards CJ, Ishii HH, Pat BK, Bryson G, Sculley TB, Gobe GC.
    Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
    [Abstract] [Full Text] [Related]

  • 5. Detection of apoptosis induced by topoisomerase inhibitors and serum deprivation in syrian hamster embryo cells.
    Alexandre S, Rast C, Nguyen-Ba G, Vasseur P.
    Exp Cell Res; 2000 Feb 25; 255(1):30-9. PubMed ID: 10666331
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of apoptotic proteins causes multidrug resistance in renal carcinoma cells.
    Scheltema JM, Romijn JC, van Steenbrugge GJ, Schröder FH, Mickisch GH.
    Anticancer Res; 2001 Feb 25; 21(5):3161-6. PubMed ID: 11848468
    [Abstract] [Full Text] [Related]

  • 7. Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis.
    Mashima T, Udagawa S, Tsuruo T.
    J Cell Physiol; 2001 Sep 25; 188(3):352-8. PubMed ID: 11473362
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.
    Henkels KM, Turchi JJ.
    Cancer Res; 1999 Jul 01; 59(13):3077-83. PubMed ID: 10397248
    [Abstract] [Full Text] [Related]

  • 9. Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.
    Lindenboim L, Yuan J, Stein R.
    Oncogene; 2000 Mar 30; 19(14):1783-93. PubMed ID: 10777212
    [Abstract] [Full Text] [Related]

  • 10. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M, Nakashima S, Banno Y, Yamakawa H, Takenaka K, Shinoda J, Nishimura Y, Sakai N, Nozawa Y.
    Oncogene; 2000 Jul 20; 19(31):3508-20. PubMed ID: 10918609
    [Abstract] [Full Text] [Related]

  • 11. Expression and regulation of genes associated with cell death during murine preimplantation embryo development.
    Jurisicova A, Latham KE, Casper RF, Casper RF, Varmuza SL.
    Mol Reprod Dev; 1998 Nov 20; 51(3):243-53. PubMed ID: 9771644
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility to drug-induced apoptosis correlates with differential modulation of Bad, Bcl-2 and Bcl-xL protein levels.
    Tudor G, Aguilera A, Halverson DO, Laing ND, Sausville EA.
    Cell Death Differ; 2000 Jun 20; 7(6):574-86. PubMed ID: 10822281
    [Abstract] [Full Text] [Related]

  • 13. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A, Richon C, Meslin F, Faure F, Kauffmann A, Lecluse Y, Jalil A, Larue L, Avril MF, Chouaib S, Mehrpour M.
    Oncogene; 2006 Dec 07; 25(58):7618-34. PubMed ID: 16983347
    [Abstract] [Full Text] [Related]

  • 14. [Mechanisms of drug resistance of two cell lines of human chronic promyelocytic leukemia K562, resistant to DNA topoisomerase II inhibitors adriamycin and etoposide].
    Meliksetian MB, Berezkina EV, Pavlenko MA, Grinchuk TM.
    Tsitologiia; 1999 Dec 07; 41(7):615-21. PubMed ID: 10496023
    [Abstract] [Full Text] [Related]

  • 15. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L).
    Ke H, Pei J, Ni Z, Xia H, Qi H, Woods T, Kelekar A, Tao W.
    Exp Cell Res; 2004 Aug 15; 298(2):329-38. PubMed ID: 15265683
    [Abstract] [Full Text] [Related]

  • 16. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
    Hasenjäger A, Gillissen B, Müller A, Normand G, Hemmati PG, Schuler M, Dörken B, Daniel PT.
    Oncogene; 2004 Jun 03; 23(26):4523-35. PubMed ID: 15064710
    [Abstract] [Full Text] [Related]

  • 17. Aven and Bcl-xL enhance protection against apoptosis for mammalian cells exposed to various culture conditions.
    Figueroa B, Chen S, Oyler GA, Hardwick JM, Betenbaugh MJ.
    Biotechnol Bioeng; 2004 Mar 20; 85(6):589-600. PubMed ID: 14966800
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro.
    Tezel G, Wax MB.
    Invest Ophthalmol Vis Sci; 1999 Oct 20; 40(11):2660-7. PubMed ID: 10509663
    [Abstract] [Full Text] [Related]

  • 19. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
    Floros KV, Thomadaki H, Florou D, Talieri M, Scorilas A.
    Ann N Y Acad Sci; 2006 Dec 20; 1090():89-97. PubMed ID: 17384250
    [Abstract] [Full Text] [Related]

  • 20. Induction of apoptosis by pectenotoxin-2 is mediated with the induction of DR4/DR5, Egr-1 and NAG-1, activation of caspases and modulation of the Bcl-2 family in p53-deficient Hep3B hepatocellular carcinoma cells.
    Shin DY, Kim GY, Kim ND, Jung JH, Kim SK, Kang HS, Choi YH.
    Oncol Rep; 2008 Feb 20; 19(2):517-26. PubMed ID: 18202802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.